When possible, PDF's or website links are attached to each citation
Stein, C. A., Penn, A., Van Hope, S., Dorsen, C. G., & Mangini, M. (2022). The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice. Journal of midwifery & women's health, 67(3), 373–383. https://doi.org/10.1111/jmwh.13371
Gard DE, Pleet ME, Bradley ER , Penn, AD , Gallenstein ML , Riley LS, DellaCrosse M, Garfinkle EM, Michalak EE, Woolley JD, (2021) Evaluating the risk of psilocybin for the treatment of bipolar depression: A review of the research literature and published case studies, Journal of Affective Disorders Reports, Volume 6, https://doi.org/10.1016/j.jadr.2021.100240.
Penn, A, Dorsen, CH, Hope S, Rosa, WE (2021) Psychedelic-Assisted Therapy: Emerging Therapies in Mental Health. American Journal of Nursing, 121(6)
Hendin, H. M., & Penn, A. (2021). An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report. Bipolar disorders, 10.1111/bdi.13095. https://doi.org/10.1111/bdi.13095
Penn, A, Rosa, WE, Phelps J, Watson, J (2021) Psychedelic Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-informed Model of Treatment
Journal of Humanistic Psychology
Rosa, WE, Dorsen CG, Penn, AD (2020) Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness, Journal of Palliative Medicine, 23(10)
Penn, A (2019) Cannabinoids and Mental Health, Part 2 The Search for Clinical Applications. Journal of Psychosocial Nursing 57(10)
Penn, A (2019) Cannabinoids and Mental Health, Part 1: The Endocannabinoid System and Exogenous Cannabinoids, Journal of Psychosocial Nursing 57(9)
Penn, A, Ot’alora, M, Raison, C (2018) MDMA-Assisted Psychotherapy for Post Traumatic Stress Disorder, Chapter in the Casebook of Positive Psychiatry, American Psychiatric Association Press (https://www.appi.org/Positive_Psychiatry_A_Casebook)
How I Joined the Secret SSRI Circles of 1985
Op-Ed: Nurses are crucial to the pandemic response. Why aren’t they on Biden’s COVID-19 board?
Los Angeles Times